Changes in cellular Ca2+ and Na+ regulation during the progression towards heart failure

Kenneth T MacLeod1

  • 1National Heart & Lung Institute, Imperial Centre for Translational and Experimental Medicine, Imperial College, Hammersmith Hospital, London, UK.

Insights

The heart adapts to injury through structural and electrical changes, but these adaptations increase arrhythmia risk and lead to heart failure. Understanding these maladaptive changes is crucial for improving patient outcomes.

Area of Science:

  • Cardiovascular Physiology
  • Cardiac Electrophysiology
  • Heart Failure Pathophysiology

Background:

  • The heart exhibits significant phenotypic plasticity in response to disease and tissue loss.
  • While initial cardiac dysfunction is compensated by structural and electrophysiological adaptations, long-term failure and arrhythmias are common.

Purpose of the Study:

  • To elucidate the molecular and cellular mechanisms underlying the heart's adaptive responses to injury.
  • To explain how these adaptations paradoxically contribute to arrhythmogenesis and heart failure.

Main Methods:

  • Analysis of myocyte ion handling, including sodium (Na+) and calcium (Ca2+) fluxes.
  • Investigation of sarcoplasmic reticulum (SR) Ca2+ ATPase function and Ca2+ uptake.
  • Examination of action potential duration, ion channel activity, and T-tubule structure.

Main Results:

  • Increased myocyte Na+ gain alters Ca2+ handling, compromising mitochondrial energy metabolism.
  • Reduced SR Ca2+ uptake and increased Ca2+ influx elevate diastolic cytosolic Ca2+, promoting delayed afterdepolarizations.
  • Prolonged action potential duration and altered ion channel function increase early afterdepolarization risk.
  • Decreased T-tubule density impairs excitation-contraction coupling, causing delays in SR Ca2+ release.

Conclusions:

  • Compensatory structural and electrophysiological changes in the heart increase arrhythmogenesis risk.
  • These adaptations activate hypertrophic, apoptotic, and Ca2+ signaling pathways.
  • The efficiency of SR Ca2+ release is diminished, contributing to overall cardiac dysfunction.

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
31
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.8K
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
469
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
495
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
132
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
46